| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 6.44e-06 | 44 | 55 | 4 | GO:0140938 | |
| GeneOntologyMolecularFunction | receptor ligand activity | 1.68e-05 | 547 | 55 | 9 | GO:0048018 | |
| GeneOntologyMolecularFunction | signaling receptor activator activity | 1.86e-05 | 554 | 55 | 9 | GO:0030546 | |
| GeneOntologyMolecularFunction | protein-lysine N-methyltransferase activity | 3.68e-05 | 68 | 55 | 4 | GO:0016279 | |
| GeneOntologyMolecularFunction | lysine N-methyltransferase activity | 3.90e-05 | 69 | 55 | 4 | GO:0016278 | |
| GeneOntologyMolecularFunction | signaling receptor regulator activity | 4.27e-05 | 616 | 55 | 9 | GO:0030545 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 4.36e-05 | 71 | 55 | 4 | GO:0042054 | |
| GeneOntologyMolecularFunction | type III transforming growth factor beta receptor binding | 4.45e-05 | 4 | 55 | 2 | GO:0034714 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 4.45e-05 | 4 | 55 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | fibroblast growth factor receptor binding | 6.87e-05 | 29 | 55 | 3 | GO:0005104 | |
| GeneOntologyMolecularFunction | melanocortin receptor binding | 7.41e-05 | 5 | 55 | 2 | GO:0031779 | |
| GeneOntologyMolecularFunction | S-adenosylmethionine-dependent methyltransferase activity | 1.10e-04 | 172 | 55 | 5 | GO:0008757 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 1.11e-04 | 6 | 55 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | ubiquitin conjugating enzyme binding | 1.32e-04 | 36 | 55 | 3 | GO:0031624 | |
| GeneOntologyMolecularFunction | zinc ion binding | POLR3K RNF125 SEC24C TRIM42 CTCF SUV39H1 ARIH2 ZIM2 ADAMTS20 RNF217 | 1.40e-04 | 891 | 55 | 10 | GO:0008270 |
| GeneOntologyMolecularFunction | chromatin insulator sequence binding | 1.55e-04 | 7 | 55 | 2 | GO:0043035 | |
| GeneOntologyMolecularFunction | neuropeptide receptor binding | 1.68e-04 | 39 | 55 | 3 | GO:0071855 | |
| GeneOntologyMolecularFunction | protein methyltransferase activity | 1.86e-04 | 103 | 55 | 4 | GO:0008276 | |
| GeneOntologyMolecularFunction | N-methyltransferase activity | 2.00e-04 | 105 | 55 | 4 | GO:0008170 | |
| GeneOntologyMolecularFunction | chromatin loop anchoring activity | 2.06e-04 | 8 | 55 | 2 | GO:0140587 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein conjugating enzyme binding | 2.10e-04 | 42 | 55 | 3 | GO:0044390 | |
| GeneOntologyMolecularFunction | DNA-DNA tethering activity | 2.65e-04 | 9 | 55 | 2 | GO:0106260 | |
| GeneOntologyMolecularFunction | methyltransferase activity | 2.97e-04 | 213 | 55 | 5 | GO:0008168 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 3.31e-04 | 10 | 55 | 2 | GO:0140999 | |
| GeneOntologyMolecularFunction | transition metal ion binding | POLR3K RNF125 SEC24C TRIM42 CTCF SUV39H1 ARIH2 OGFOD2 ZIM2 ADAMTS20 RNF217 | 3.38e-04 | 1189 | 55 | 11 | GO:0046914 |
| GeneOntologyMolecularFunction | transferase activity, transferring one-carbon groups | 3.74e-04 | 224 | 55 | 5 | GO:0016741 | |
| GeneOntologyMolecularFunction | histone modifying activity | 4.14e-04 | 229 | 55 | 5 | GO:0140993 | |
| GeneOntologyMolecularFunction | type II transforming growth factor beta receptor binding | 4.83e-04 | 12 | 55 | 2 | GO:0005114 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | KMT2C LIMD1 LMO1 CTCF LMO3 FLRT3 FLRT2 FLRT1 EZH2 SPPL2C MSL2 | 1.02e-03 | 1356 | 55 | 11 | GO:0060090 |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 1.11e-03 | 18 | 55 | 2 | GO:0015278 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | 1.15e-03 | 167 | 55 | 4 | GO:0031490 | |
| GeneOntologyMolecularFunction | growth factor receptor binding | 1.32e-03 | 173 | 55 | 4 | GO:0070851 | |
| GeneOntologyMolecularFunction | growth factor activity | 1.32e-03 | 173 | 55 | 4 | GO:0008083 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 1.37e-03 | 20 | 55 | 2 | GO:0042800 | |
| GeneOntologyMolecularFunction | molecular function activator activity | 1.78e-03 | 1233 | 55 | 10 | GO:0140677 | |
| GeneOntologyMolecularFunction | chemorepellent activity | 2.88e-03 | 29 | 55 | 2 | GO:0045499 | |
| GeneOntologyMolecularFunction | transforming growth factor beta receptor binding | 3.29e-03 | 31 | 55 | 2 | GO:0005160 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 3.29e-03 | 31 | 55 | 2 | GO:0099604 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 3.72e-03 | 33 | 55 | 2 | GO:0005217 | |
| GeneOntologyMolecularFunction | neuropeptide hormone activity | 3.95e-03 | 34 | 55 | 2 | GO:0005184 | |
| GeneOntologyMolecularFunction | neuropeptide activity | 3.95e-03 | 34 | 55 | 2 | GO:0160041 | |
| GeneOntologyMolecularFunction | cytokine activity | 4.96e-03 | 250 | 55 | 4 | GO:0005125 | |
| GeneOntologyMolecularFunction | amide binding | 9.23e-03 | 299 | 55 | 4 | GO:0033218 | |
| GeneOntologyBiologicalProcess | epigenetic programming of gene expression | 1.33e-07 | 49 | 51 | 5 | GO:0043045 | |
| GeneOntologyBiologicalProcess | uterine wall breakdown | 5.99e-06 | 2 | 51 | 2 | GO:0042704 | |
| GeneOntologyBiologicalProcess | epigenetic programming in the zygotic pronuclei | 9.45e-06 | 17 | 51 | 3 | GO:0044725 | |
| GeneOntologyBiologicalProcess | facultative heterochromatin formation | 1.03e-05 | 55 | 51 | 4 | GO:0140718 | |
| GeneOntologyBiologicalProcess | epigenetic regulation of gene expression | 1.59e-05 | 330 | 51 | 7 | GO:0040029 | |
| GeneOntologyBiologicalProcess | response to hypoxia | 2.24e-05 | 348 | 51 | 7 | GO:0001666 | |
| GeneOntologyBiologicalProcess | response to decreased oxygen levels | 2.99e-05 | 364 | 51 | 7 | GO:0036293 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | 7.46e-05 | 741 | 51 | 9 | GO:0006338 | |
| GeneOntologyBiologicalProcess | response to oxygen levels | 8.55e-05 | 430 | 51 | 7 | GO:0070482 | |
| GeneOntologyBiologicalProcess | genomic imprinting | 8.81e-05 | 35 | 51 | 3 | GO:0071514 | |
| GeneOntologyBiologicalProcess | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation | 8.93e-05 | 6 | 51 | 2 | GO:1905005 | |
| GeneOntologyBiologicalProcess | fibroblast growth factor receptor signaling pathway | 1.01e-04 | 98 | 51 | 4 | GO:0008543 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 1.04e-04 | 37 | 51 | 3 | GO:0014808 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by endoplasmic reticulum | 1.22e-04 | 39 | 51 | 3 | GO:1903514 | |
| GeneOntologyBiologicalProcess | embryo development | VEGFC TGFB2 TGFB3 SEC24C CTCF SUV39H1 WNT9A GRN FLRT3 PLXNB2 ITGB1 RYR2 | 1.55e-04 | 1437 | 51 | 12 | GO:0009790 |
| GeneOntologyBiologicalProcess | DNA methylation-dependent constitutive heterochromatin formation | 1.76e-04 | 44 | 51 | 3 | GO:0006346 | |
| GeneOntologyBiologicalProcess | sarcoplasmic reticulum calcium ion transport | 1.76e-04 | 44 | 51 | 3 | GO:0070296 | |
| GeneOntologyBiologicalProcess | cell adhesion involved in heart morphogenesis | 2.13e-04 | 9 | 51 | 2 | GO:0061343 | |
| GeneOntologyBiologicalProcess | positive regulation of heart contraction | 2.42e-04 | 49 | 51 | 3 | GO:0045823 | |
| GeneOntologyBiologicalProcess | cellular response to fibroblast growth factor stimulus | 2.50e-04 | 124 | 51 | 4 | GO:0044344 | |
| GeneOntologyBiologicalProcess | rhythmic process | 2.52e-04 | 360 | 51 | 6 | GO:0048511 | |
| GeneOntologyBiologicalProcess | negative regulation of keratinocyte differentiation | 2.66e-04 | 10 | 51 | 2 | GO:0045617 | |
| GeneOntologyBiologicalProcess | methylation | 2.76e-04 | 234 | 51 | 5 | GO:0032259 | |
| GeneOntologyBiologicalProcess | positive regulation of blood circulation | 3.06e-04 | 53 | 51 | 3 | GO:1903524 | |
| GeneOntologyBiologicalProcess | chromatin organization | 3.11e-04 | 896 | 51 | 9 | GO:0006325 | |
| GeneOntologyBiologicalProcess | response to fibroblast growth factor | 3.17e-04 | 132 | 51 | 4 | GO:0071774 | |
| GeneOntologyBiologicalProcess | adult feeding behavior | 3.25e-04 | 11 | 51 | 2 | GO:0008343 | |
| GeneOntologyBiologicalProcess | cellular response to caffeine | 3.25e-04 | 11 | 51 | 2 | GO:0071313 | |
| GeneOntologyBiologicalProcess | embryonic neurocranium morphogenesis | 3.25e-04 | 11 | 51 | 2 | GO:0048702 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | 3.38e-04 | 906 | 51 | 9 | GO:0043009 | |
| GeneOntologyBiologicalProcess | developmental growth | 3.52e-04 | 911 | 51 | 9 | GO:0048589 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | 4.06e-04 | 929 | 51 | 9 | GO:0009792 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol | 4.65e-04 | 146 | 51 | 4 | GO:0051209 | |
| GeneOntologyBiologicalProcess | negative regulation of sequestering of calcium ion | 4.77e-04 | 147 | 51 | 4 | GO:0051283 | |
| GeneOntologyBiologicalProcess | heart development | 4.99e-04 | 757 | 51 | 8 | GO:0007507 | |
| GeneOntologyBiologicalProcess | regulation of sequestering of calcium ion | 5.02e-04 | 149 | 51 | 4 | GO:0051282 | |
| GeneOntologyBiologicalProcess | positive regulation of epithelial to mesenchymal transition | 5.09e-04 | 63 | 51 | 3 | GO:0010718 | |
| GeneOntologyBiologicalProcess | regulation of cardiac epithelial to mesenchymal transition | 5.35e-04 | 14 | 51 | 2 | GO:0062042 | |
| GeneOntologyBiologicalProcess | negative regulation of macrophage cytokine production | 5.35e-04 | 14 | 51 | 2 | GO:0010936 | |
| GeneOntologyBiologicalProcess | cellular response to purine-containing compound | 5.35e-04 | 14 | 51 | 2 | GO:0071415 | |
| GeneOntologyBiologicalProcess | sequestering of calcium ion | 5.55e-04 | 153 | 51 | 4 | GO:0051208 | |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | 5.57e-04 | 418 | 51 | 6 | GO:0051962 | |
| GeneOntologyBiologicalProcess | multicellular organismal reproductive process | 5.90e-04 | 1194 | 51 | 10 | GO:0048609 | |
| GeneOntologyBiologicalProcess | regulation of cell shape | 6.41e-04 | 159 | 51 | 4 | GO:0008360 | |
| GeneOntologyBiologicalProcess | circulatory system development | VEGFC TGFB2 TGFB3 CTCF GRN FLRT3 FLRT2 ITGB1 ITGB2 RYR1 RYR2 | 6.63e-04 | 1442 | 51 | 11 | GO:0072359 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | 6.86e-04 | 999 | 51 | 9 | GO:0071824 | |
| GeneOntologyBiologicalProcess | heterochromatin formation | 7.03e-04 | 163 | 51 | 4 | GO:0031507 | |
| GeneOntologyBiologicalProcess | negative regulation of epidermis development | 7.04e-04 | 16 | 51 | 2 | GO:0045683 | |
| GeneOntologyBiologicalProcess | negative regulation of epidermal cell differentiation | 7.04e-04 | 16 | 51 | 2 | GO:0045605 | |
| GeneOntologyBiologicalProcess | regulation of nervous system development | 8.25e-04 | 625 | 51 | 7 | GO:0051960 | |
| GeneOntologyBiologicalProcess | cardioblast differentiation | 8.94e-04 | 18 | 51 | 2 | GO:0010002 | |
| GeneOntologyBiologicalProcess | epithelial to mesenchymal transition involved in endocardial cushion formation | 9.98e-04 | 19 | 51 | 2 | GO:0003198 | |
| GeneOntologyBiologicalProcess | positive regulation of sequestering of calcium ion | 9.98e-04 | 19 | 51 | 2 | GO:0051284 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 1.03e-03 | 313 | 51 | 5 | GO:0098742 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | 1.06e-03 | 850 | 51 | 8 | GO:0071363 | |
| GeneOntologyBiologicalProcess | heart morphogenesis | 1.16e-03 | 321 | 51 | 5 | GO:0003007 | |
| GeneOntologyBiologicalProcess | regulation of cytosolic calcium ion concentration | 1.18e-03 | 84 | 51 | 3 | GO:0051480 | |
| GeneOntologyBiologicalProcess | response to caffeine | 1.22e-03 | 21 | 51 | 2 | GO:0031000 | |
| GeneOntologyBiologicalProcess | positive regulation of synapse assembly | 1.26e-03 | 86 | 51 | 3 | GO:0051965 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion | 1.34e-03 | 22 | 51 | 2 | GO:0010881 | |
| GeneOntologyBiologicalProcess | response to growth factor | 1.36e-03 | 883 | 51 | 8 | GO:0070848 | |
| GeneOntologyBiologicalProcess | cell adhesion mediated by integrin | 1.48e-03 | 91 | 51 | 3 | GO:0033627 | |
| GeneOntologyBiologicalProcess | regulation of cell division | 1.53e-03 | 201 | 51 | 4 | GO:0051302 | |
| GeneOntologyBiologicalProcess | negative regulation of gene expression, epigenetic | 1.59e-03 | 203 | 51 | 4 | GO:0045814 | |
| GeneOntologyBiologicalProcess | response to abiotic stimulus | 1.61e-03 | 1361 | 51 | 10 | GO:0009628 | |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | 1.66e-03 | 705 | 51 | 7 | GO:0055080 | |
| GeneOntologyBiologicalProcess | regulation of protein phosphorylation | 1.66e-03 | 1133 | 51 | 9 | GO:0001932 | |
| GeneOntologyBiologicalProcess | ovulation cycle | 1.68e-03 | 95 | 51 | 3 | GO:0042698 | |
| GeneOntologyBiologicalProcess | cardiac left ventricle morphogenesis | 1.73e-03 | 25 | 51 | 2 | GO:0003214 | |
| GeneOntologyBiologicalProcess | negative regulation of cytosolic calcium ion concentration | 1.73e-03 | 25 | 51 | 2 | GO:0051481 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | 1.75e-03 | 1141 | 51 | 9 | GO:0045597 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | 1.77e-03 | 713 | 51 | 7 | GO:0048598 | |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | 1.82e-03 | 717 | 51 | 7 | GO:0050801 | |
| GeneOntologyBiologicalProcess | regulation of release of sequestered calcium ion into cytosol | 1.84e-03 | 98 | 51 | 3 | GO:0051279 | |
| GeneOntologyBiologicalProcess | cell communication by electrical coupling involved in cardiac conduction | 1.88e-03 | 26 | 51 | 2 | GO:0086064 | |
| GeneOntologyBiologicalProcess | intracellular calcium ion homeostasis | 1.89e-03 | 359 | 51 | 5 | GO:0006874 | |
| GeneOntologyBiologicalProcess | neuroinflammatory response | 2.00e-03 | 101 | 51 | 3 | GO:0150076 | |
| GeneOntologyBiologicalProcess | sensory organ development | 2.02e-03 | 730 | 51 | 7 | GO:0007423 | |
| GeneOntologyBiologicalProcess | secondary palate development | 2.02e-03 | 27 | 51 | 2 | GO:0062009 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 2.02e-03 | 217 | 51 | 4 | GO:0097553 | |
| GeneOntologyBiologicalProcess | positive regulation of angiogenesis | 2.13e-03 | 220 | 51 | 4 | GO:0045766 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction by calcium ion signaling | 2.17e-03 | 28 | 51 | 2 | GO:0010882 | |
| GeneOntologyBiologicalProcess | positive regulation of cell division | 2.18e-03 | 104 | 51 | 3 | GO:0051781 | |
| GeneOntologyBiologicalProcess | neuroblast proliferation | 2.18e-03 | 104 | 51 | 3 | GO:0007405 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculature development | 2.23e-03 | 223 | 51 | 4 | GO:1904018 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | 2.35e-03 | 750 | 51 | 7 | GO:0048729 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | 2.38e-03 | 1194 | 51 | 9 | GO:0000902 | |
| GeneOntologyBiologicalProcess | embryonic skeletal system morphogenesis | 2.49e-03 | 109 | 51 | 3 | GO:0048704 | |
| GeneOntologyBiologicalProcess | cell junction organization | 2.51e-03 | 974 | 51 | 8 | GO:0034330 | |
| GeneOntologyCellularComponent | extracellular matrix | TGFB2 TGFB3 SBSPON ADAMTS20 COL6A5 MUC5B FLRT3 FLRT2 FLRT1 PLXNB2 ITGB1 OTOG | 6.78e-08 | 656 | 53 | 12 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | TGFB2 TGFB3 SBSPON ADAMTS20 COL6A5 MUC5B FLRT3 FLRT2 FLRT1 PLXNB2 ITGB1 OTOG | 7.01e-08 | 658 | 53 | 12 | GO:0030312 |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 2.03e-04 | 45 | 53 | 3 | GO:0033017 | |
| GeneOntologyCellularComponent | junctional sarcoplasmic reticulum membrane | 2.80e-04 | 10 | 53 | 2 | GO:0014701 | |
| GeneOntologyCellularComponent | cerebellar climbing fiber to Purkinje cell synapse | 3.42e-04 | 11 | 53 | 2 | GO:0150053 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 3.63e-04 | 530 | 53 | 7 | GO:0062023 | |
| GeneOntologyCellularComponent | chromatin silencing complex | 5.63e-04 | 14 | 53 | 2 | GO:0005677 | |
| GeneOntologyCellularComponent | platelet alpha granule lumen | 6.57e-04 | 67 | 53 | 3 | GO:0031093 | |
| GeneOntologyCellularComponent | focal adhesion | 7.51e-04 | 431 | 53 | 6 | GO:0005925 | |
| GeneOntologyCellularComponent | ESC/E(Z) complex | 8.37e-04 | 17 | 53 | 2 | GO:0035098 | |
| GeneOntologyCellularComponent | cell-substrate junction | 8.66e-04 | 443 | 53 | 6 | GO:0030055 | |
| GeneOntologyCellularComponent | histone methyltransferase complex | 9.13e-04 | 75 | 53 | 3 | GO:0035097 | |
| GeneOntologyCellularComponent | sarcolemma | 1.37e-03 | 190 | 53 | 4 | GO:0042383 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 1.45e-03 | 88 | 53 | 3 | GO:0016529 | |
| GeneOntologyCellularComponent | asymmetric, glutamatergic, excitatory synapse | 1.68e-03 | 24 | 53 | 2 | GO:0098985 | |
| GeneOntologyCellularComponent | platelet alpha granule | 1.70e-03 | 93 | 53 | 3 | GO:0031091 | |
| GeneOntologyCellularComponent | heterochromatin | 2.15e-03 | 101 | 53 | 3 | GO:0000792 | |
| GeneOntologyCellularComponent | methyltransferase complex | 2.60e-03 | 108 | 53 | 3 | GO:0034708 | |
| GeneOntologyCellularComponent | integrin complex | 2.98e-03 | 32 | 53 | 2 | GO:0008305 | |
| GeneOntologyCellularComponent | sarcoplasm | 3.03e-03 | 114 | 53 | 3 | GO:0016528 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | 4.85e-03 | 1293 | 53 | 9 | GO:0005789 | |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | 5.00e-03 | 1299 | 53 | 9 | GO:0098827 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | 5.74e-03 | 1327 | 53 | 9 | GO:0042175 | |
| GeneOntologyCellularComponent | smooth endoplasmic reticulum | 6.08e-03 | 46 | 53 | 2 | GO:0005790 | |
| GeneOntologyCellularComponent | Z disc | 6.65e-03 | 151 | 53 | 3 | GO:0030018 | |
| GeneOntologyCellularComponent | PcG protein complex | 7.71e-03 | 52 | 53 | 2 | GO:0031519 | |
| GeneOntologyCellularComponent | I band | 8.62e-03 | 166 | 53 | 3 | GO:0031674 | |
| GeneOntologyCellularComponent | extrinsic component of cytoplasmic side of plasma membrane | 8.90e-03 | 56 | 53 | 2 | GO:0031234 | |
| Domain | SET | 6.76e-06 | 41 | 56 | 4 | PF00856 | |
| Domain | Agouti | 8.83e-06 | 2 | 56 | 2 | SM00792 | |
| Domain | Agouti | 8.83e-06 | 2 | 56 | 2 | PF05039 | |
| Domain | AGOUTI_2 | 8.83e-06 | 2 | 56 | 2 | PS51150 | |
| Domain | - | 8.83e-06 | 2 | 56 | 2 | 4.10.760.10 | |
| Domain | Agouti | 8.83e-06 | 2 | 56 | 2 | IPR007733 | |
| Domain | AGOUTI_1 | 8.83e-06 | 2 | 56 | 2 | PS60024 | |
| Domain | Agouti_dom | 8.83e-06 | 2 | 56 | 2 | IPR027300 | |
| Domain | SET | 1.08e-05 | 46 | 56 | 4 | SM00317 | |
| Domain | SET_dom | 1.51e-05 | 50 | 56 | 4 | IPR001214 | |
| Domain | SET | 1.51e-05 | 50 | 56 | 4 | PS50280 | |
| Domain | Ryanrecept_TM4-6 | 2.64e-05 | 3 | 56 | 2 | IPR009460 | |
| Domain | RyR | 2.64e-05 | 3 | 56 | 2 | PF02026 | |
| Domain | Ryanodine_rcpt | 2.64e-05 | 3 | 56 | 2 | IPR003032 | |
| Domain | RR_TM4-6 | 2.64e-05 | 3 | 56 | 2 | PF06459 | |
| Domain | TGF-beta | 2.64e-05 | 3 | 56 | 2 | IPR016319 | |
| Domain | Ryan_recept | 2.64e-05 | 3 | 56 | 2 | IPR013333 | |
| Domain | Znf_RING/FYVE/PHD | 6.32e-05 | 459 | 56 | 8 | IPR013083 | |
| Domain | - | 7.13e-05 | 74 | 56 | 4 | 3.40.50.410 | |
| Domain | RIH_assoc | 1.31e-04 | 6 | 56 | 2 | PF08454 | |
| Domain | RIH_assoc-dom | 1.31e-04 | 6 | 56 | 2 | IPR013662 | |
| Domain | RIH_dom | 1.31e-04 | 6 | 56 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.31e-04 | 6 | 56 | 2 | IPR014821 | |
| Domain | Tesmin/TSO1-like_CXC | 1.31e-04 | 6 | 56 | 2 | IPR033467 | |
| Domain | Integrin_bsu_cyt_dom | 1.31e-04 | 6 | 56 | 2 | IPR014836 | |
| Domain | Ryanodine_recept-rel | 1.31e-04 | 6 | 56 | 2 | IPR015925 | |
| Domain | ZF_HIT | 1.31e-04 | 6 | 56 | 2 | PS51083 | |
| Domain | - | 1.31e-04 | 6 | 56 | 2 | 1.25.10.30 | |
| Domain | zf-HIT | 1.31e-04 | 6 | 56 | 2 | PF04438 | |
| Domain | RYDR_ITPR | 1.31e-04 | 6 | 56 | 2 | PF01365 | |
| Domain | Znf_HIT | 1.31e-04 | 6 | 56 | 2 | IPR007529 | |
| Domain | CXC | 1.31e-04 | 6 | 56 | 2 | SM01114 | |
| Domain | Ins145_P3_rec | 1.31e-04 | 6 | 56 | 2 | PF08709 | |
| Domain | Integrin_b_cyt | 1.31e-04 | 6 | 56 | 2 | SM01241 | |
| Domain | Integrin_b_cyt | 1.31e-04 | 6 | 56 | 2 | PF08725 | |
| Domain | Integrin_bsu_tail | 1.84e-04 | 7 | 56 | 2 | IPR012896 | |
| Domain | Integrin_B_tail | 1.84e-04 | 7 | 56 | 2 | SM01242 | |
| Domain | Integrin_B_tail | 1.84e-04 | 7 | 56 | 2 | PF07965 | |
| Domain | VWF_A | 2.21e-04 | 99 | 56 | 4 | IPR002035 | |
| Domain | Integrin_beta | 2.44e-04 | 8 | 56 | 2 | PF00362 | |
| Domain | INB | 2.44e-04 | 8 | 56 | 2 | SM00187 | |
| Domain | Integrin_bsu_VWA | 2.44e-04 | 8 | 56 | 2 | IPR002369 | |
| Domain | ZF_RING_2 | 2.61e-04 | 298 | 56 | 6 | PS50089 | |
| Domain | PSI | 3.10e-04 | 44 | 56 | 3 | IPR016201 | |
| Domain | Integrin_bsu | 3.14e-04 | 9 | 56 | 2 | IPR015812 | |
| Domain | Integin_beta_N | 3.14e-04 | 9 | 56 | 2 | IPR033760 | |
| Domain | INTEGRIN_BETA | 3.14e-04 | 9 | 56 | 2 | PS00243 | |
| Domain | PSI_integrin | 3.14e-04 | 9 | 56 | 2 | PF17205 | |
| Domain | PSI | 3.54e-04 | 46 | 56 | 3 | SM00423 | |
| Domain | - | 3.71e-04 | 449 | 56 | 7 | 3.30.40.10 | |
| Domain | MIR | 3.91e-04 | 10 | 56 | 2 | PS50919 | |
| Domain | MIR | 3.91e-04 | 10 | 56 | 2 | PF02815 | |
| Domain | MIR | 3.91e-04 | 10 | 56 | 2 | SM00472 | |
| Domain | E3_UB_ligase_RBR | 3.91e-04 | 10 | 56 | 2 | IPR031127 | |
| Domain | MIR_motif | 3.91e-04 | 10 | 56 | 2 | IPR016093 | |
| Domain | LRRNT | 5.38e-04 | 53 | 56 | 3 | PF01462 | |
| Domain | TIL | 5.72e-04 | 12 | 56 | 2 | PF01826 | |
| Domain | C8 | 5.72e-04 | 12 | 56 | 2 | PF08742 | |
| Domain | Unchr_dom_Cys-rich | 6.74e-04 | 13 | 56 | 2 | IPR014853 | |
| Domain | C8 | 6.74e-04 | 13 | 56 | 2 | SM00832 | |
| Domain | IBR | 7.85e-04 | 14 | 56 | 2 | SM00647 | |
| Domain | TIL_dom | 7.85e-04 | 14 | 56 | 2 | IPR002919 | |
| Domain | IBR | 7.85e-04 | 14 | 56 | 2 | PF01485 | |
| Domain | IBR_dom | 9.04e-04 | 15 | 56 | 2 | IPR002867 | |
| Domain | Znf_FYVE_PHD | 9.85e-04 | 147 | 56 | 4 | IPR011011 | |
| Domain | Post-SET_dom | 1.03e-03 | 16 | 56 | 2 | IPR003616 | |
| Domain | VWD | 1.03e-03 | 16 | 56 | 2 | SM00216 | |
| Domain | PostSET | 1.03e-03 | 16 | 56 | 2 | SM00508 | |
| Domain | VWF_type-D | 1.03e-03 | 16 | 56 | 2 | IPR001846 | |
| Domain | VWFD | 1.03e-03 | 16 | 56 | 2 | PS51233 | |
| Domain | POST_SET | 1.03e-03 | 16 | 56 | 2 | PS50868 | |
| Domain | VWD | 1.03e-03 | 16 | 56 | 2 | PF00094 | |
| Domain | - | 1.07e-03 | 67 | 56 | 3 | 2.10.90.10 | |
| Domain | Cystine-knot_cytokine | 1.07e-03 | 67 | 56 | 3 | IPR029034 | |
| Domain | LIM | 1.16e-03 | 69 | 56 | 3 | PF00412 | |
| Domain | - | 1.21e-03 | 70 | 56 | 3 | 2.10.110.10 | |
| Domain | Znf_LIM | 1.26e-03 | 71 | 56 | 3 | IPR001781 | |
| Domain | LIM_DOMAIN_1 | 1.26e-03 | 71 | 56 | 3 | PS00478 | |
| Domain | LIM_DOMAIN_2 | 1.26e-03 | 71 | 56 | 3 | PS50023 | |
| Domain | LIM | 1.26e-03 | 71 | 56 | 3 | SM00132 | |
| Domain | fn3 | 1.41e-03 | 162 | 56 | 4 | PF00041 | |
| Domain | VWC_out | 1.46e-03 | 19 | 56 | 2 | SM00215 | |
| Domain | ZF_RING_1 | 1.77e-03 | 291 | 56 | 5 | PS00518 | |
| Domain | GPCR_3 | 1.79e-03 | 21 | 56 | 2 | IPR000337 | |
| Domain | VWFA | 1.91e-03 | 82 | 56 | 3 | PS50234 | |
| Domain | 7tm_3 | 1.96e-03 | 22 | 56 | 2 | PF00003 | |
| Domain | G_PROTEIN_RECEP_F3_2 | 1.96e-03 | 22 | 56 | 2 | PS00980 | |
| Domain | G_PROTEIN_RECEP_F3_3 | 1.96e-03 | 22 | 56 | 2 | PS00981 | |
| Domain | G_PROTEIN_RECEP_F3_1 | 1.96e-03 | 22 | 56 | 2 | PS00979 | |
| Domain | G_PROTEIN_RECEP_F3_4 | 1.96e-03 | 22 | 56 | 2 | PS50259 | |
| Domain | CT | 1.96e-03 | 22 | 56 | 2 | SM00041 | |
| Domain | GPCR_3_C | 1.96e-03 | 22 | 56 | 2 | IPR017978 | |
| Domain | VWA | 2.05e-03 | 84 | 56 | 3 | SM00327 | |
| Domain | FN3 | 2.29e-03 | 185 | 56 | 4 | SM00060 | |
| Domain | Cys-rich_flank_reg_C | 2.49e-03 | 90 | 56 | 3 | IPR000483 | |
| Domain | LRRCT | 2.49e-03 | 90 | 56 | 3 | SM00082 | |
| Domain | Integrin_dom | 2.53e-03 | 25 | 56 | 2 | IPR032695 | |
| Domain | Cys_knot_C | 2.53e-03 | 25 | 56 | 2 | IPR006207 | |
| Domain | CTCK_2 | 2.53e-03 | 25 | 56 | 2 | PS01225 | |
| Domain | Znf_RING | 2.90e-03 | 326 | 56 | 5 | IPR001841 | |
| Pathway | WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING | 8.50e-06 | 13 | 45 | 3 | M39589 | |
| Pathway | WP_HISTONE_MODIFICATIONS | 5.32e-05 | 65 | 45 | 4 | M39374 | |
| Pathway | BIOCARTA_CTCF_PATHWAY | 5.87e-05 | 24 | 45 | 3 | M11420 | |
| Pathway | BIOCARTA_CTCF_PATHWAY | 5.87e-05 | 24 | 45 | 3 | MM1373 | |
| Pathway | REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES | 7.12e-05 | 70 | 45 | 4 | M27231 | |
| Pathway | KEGG_LEISHMANIA_INFECTION | 7.96e-05 | 72 | 45 | 4 | M3126 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 9.83e-05 | 76 | 45 | 4 | M27219 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR1 | 1.16e-04 | 30 | 45 | 3 | MM15236 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR1 | 1.28e-04 | 31 | 45 | 3 | M27510 | |
| Pathway | KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM | 1.39e-04 | 83 | 45 | 4 | M8728 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 1.41e-04 | 32 | 45 | 3 | MM14854 | |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 1.89e-04 | 90 | 45 | 4 | M835 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 2.19e-04 | 37 | 45 | 3 | M27134 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 2.37e-04 | 38 | 45 | 3 | MM14874 | |
| Pathway | WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER | 2.56e-04 | 39 | 45 | 3 | M46456 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 2.56e-04 | 39 | 45 | 3 | MM14601 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGF_BETA_SIGNALING_PATHWAY | 2.76e-04 | 8 | 45 | 2 | M47415 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PLASMIN_MEDIATED_ACTIVATION_OF_LATENT_TGF_BETA | 2.76e-04 | 8 | 45 | 2 | M47850 | |
| Pathway | BIOCARTA_LYMPHOCYTE_PATHWAY | 3.54e-04 | 9 | 45 | 2 | MM1534 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HIF_1_SIGNALING_PATHWAY | 3.54e-04 | 9 | 45 | 2 | M47421 | |
| Pathway | BIOCARTA_LYMPHOCYTE_PATHWAY | 3.54e-04 | 9 | 45 | 2 | M22008 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 3.67e-04 | 44 | 45 | 3 | M26969 | |
| Pathway | REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES | 4.19e-04 | 46 | 45 | 3 | MM14933 | |
| Pathway | WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER | 4.19e-04 | 46 | 45 | 3 | M46466 | |
| Pathway | WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS | 4.47e-04 | 47 | 45 | 3 | M39829 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 4.47e-04 | 47 | 45 | 3 | M646 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR1 | 5.36e-04 | 50 | 45 | 3 | MM15255 | |
| Pathway | BIOCARTA_MONOCYTE_PATHWAY | 5.38e-04 | 11 | 45 | 2 | MM1436 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 5.38e-04 | 11 | 45 | 2 | M47958 | |
| Pathway | BIOCARTA_MONOCYTE_PATHWAY | 5.38e-04 | 11 | 45 | 2 | M4956 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR1 | 6.02e-04 | 52 | 45 | 3 | M27530 | |
| Pathway | WP_11P112_COPY_NUMBER_VARIATION_SYNDROME | 7.49e-04 | 56 | 45 | 3 | M48075 | |
| Pathway | KEGG_MEDICUS_VARIANT_LOSS_OF_VHL_TO_HIF_1_SIGNALING_PATHWAY | 8.85e-04 | 14 | 45 | 2 | M47422 | |
| Pathway | BIOCARTA_LYM_PATHWAY | 8.85e-04 | 14 | 45 | 2 | M1469 | |
| Pathway | BIOCARTA_ERYTH_PATHWAY | 1.02e-03 | 15 | 45 | 2 | M9367 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 1.31e-03 | 17 | 45 | 2 | MM1509 | |
| Pathway | WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE | 1.31e-03 | 17 | 45 | 2 | M39733 | |
| Pathway | WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS | 1.31e-03 | 17 | 45 | 2 | M39807 | |
| Pathway | BIOCARTA_LAIR_PATHWAY | 1.31e-03 | 17 | 45 | 2 | M3952 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.32e-03 | 68 | 45 | 3 | M27303 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.33e-03 | 258 | 45 | 5 | MM14572 | |
| Pathway | KEGG_RENAL_CELL_CARCINOMA | 1.43e-03 | 70 | 45 | 3 | M13266 | |
| Pathway | KEGG_PANCREATIC_CANCER | 1.43e-03 | 70 | 45 | 3 | M9726 | |
| Pathway | BIOCARTA_ERYTH_PATHWAY | 1.48e-03 | 18 | 45 | 2 | MM1392 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 1.65e-03 | 19 | 45 | 2 | M18933 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.65e-03 | 19 | 45 | 2 | M47760 | |
| Pathway | BIOCARTA_TOB1_PATHWAY | 1.65e-03 | 19 | 45 | 2 | M18215 | |
| Pathway | BIOCARTA_TOB1_PATHWAY | 1.65e-03 | 19 | 45 | 2 | MM1490 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 1.68e-03 | 272 | 45 | 5 | M29619 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 1.70e-03 | 161 | 45 | 4 | M39770 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.82e-03 | 76 | 45 | 3 | MM14867 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR | 1.89e-03 | 77 | 45 | 3 | MM14722 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 1.89e-03 | 77 | 45 | 3 | MM14670 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 2.01e-03 | 418 | 45 | 6 | MM15587 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 2.30e-03 | 175 | 45 | 4 | MM14941 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 2.50e-03 | 85 | 45 | 3 | M16441 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | 2.57e-03 | 439 | 45 | 6 | M42563 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.57e-03 | 300 | 45 | 5 | M610 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR | 2.85e-03 | 89 | 45 | 3 | M1090 | |
| Pathway | PID_INTEGRIN_A9B1_PATHWAY | 2.85e-03 | 25 | 45 | 2 | M118 | |
| Pathway | PID_LYMPH_ANGIOGENESIS_PATHWAY | 2.85e-03 | 25 | 45 | 2 | M274 | |
| Pathway | BIOCARTA_NKT_PATHWAY | 3.08e-03 | 26 | 45 | 2 | M4047 | |
| Pathway | PID_INTEGRIN_CS_PATHWAY | 3.08e-03 | 26 | 45 | 2 | M47 | |
| Pathway | PID_GLYPICAN_1PATHWAY | 3.32e-03 | 27 | 45 | 2 | M33 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 3.33e-03 | 94 | 45 | 3 | M1041 | |
| Pathway | BIOCARTA_G1_PATHWAY | 3.57e-03 | 28 | 45 | 2 | M648 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 3.62e-03 | 325 | 45 | 5 | M12868 | |
| Pathway | WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION | 3.83e-03 | 29 | 45 | 2 | M39797 | |
| Pathway | WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS | 3.83e-03 | 29 | 45 | 2 | M39516 | |
| Pathway | BIOCARTA_INFLAM_PATHWAY | 3.83e-03 | 29 | 45 | 2 | M6910 | |
| Pathway | BIOCARTA_G1_PATHWAY | 3.83e-03 | 29 | 45 | 2 | MM1364 | |
| Pathway | BIOCARTA_IL1R_PATHWAY | 4.37e-03 | 31 | 45 | 2 | M12095 | |
| Pathway | BIOCARTA_P38MAPK_PATHWAY | 4.65e-03 | 32 | 45 | 2 | MM1450 | |
| Pathway | BIOCARTA_NKT_PATHWAY | 4.65e-03 | 32 | 45 | 2 | MM1492 | |
| Pathway | WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY | 4.66e-03 | 106 | 45 | 3 | M42535 | |
| Pathway | WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R | 4.94e-03 | 33 | 45 | 2 | M39803 | |
| Pathway | BIOCARTA_INFLAM_PATHWAY | 4.94e-03 | 33 | 45 | 2 | MM1379 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 5.04e-03 | 109 | 45 | 3 | MM15164 | |
| Pathway | WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA | 5.24e-03 | 34 | 45 | 2 | M39771 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 5.30e-03 | 111 | 45 | 3 | M27416 | |
| Pathway | BIOCARTA_P38MAPK_PATHWAY | 5.86e-03 | 36 | 45 | 2 | M862 | |
| Pathway | BIOCARTA_ALK_PATHWAY | 6.18e-03 | 37 | 45 | 2 | M17400 | |
| Pathway | WP_NEOVASCULARIZATION_PROCESSES | 6.18e-03 | 37 | 45 | 2 | M39506 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 6.28e-03 | 118 | 45 | 3 | MM15588 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 6.55e-03 | 532 | 45 | 6 | M27870 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 6.85e-03 | 39 | 45 | 2 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 6.85e-03 | 39 | 45 | 2 | MM15165 | |
| Pathway | REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS | 6.89e-03 | 122 | 45 | 3 | M29689 | |
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 10644439 | ||
| Pubmed | FLRT3 Marks Direction-Selective Retinal Ganglion Cells That Project to the Medial Terminal Nucleus. | 1.58e-08 | 4 | 56 | 3 | 34955746 | |
| Pubmed | 1.58e-08 | 4 | 56 | 3 | 16872596 | ||
| Pubmed | Structural Basis of Teneurin-Latrophilin Interaction in Repulsive Guidance of Migrating Neurons. | 1.58e-08 | 4 | 56 | 3 | 31928845 | |
| Pubmed | 1.38e-07 | 7 | 56 | 3 | 9427478 | ||
| Pubmed | 4.71e-07 | 10 | 56 | 3 | 17048991 | ||
| Pubmed | 4.71e-07 | 10 | 56 | 3 | 38713721 | ||
| Pubmed | 7.80e-07 | 44 | 56 | 4 | 24183668 | ||
| Pubmed | FLRT2 and FLRT3 act as repulsive guidance cues for Unc5-positive neurons. | 8.61e-07 | 12 | 56 | 3 | 21673655 | |
| Pubmed | Regulation of Cerebral Cortex Folding by Controlling Neuronal Migration via FLRT Adhesion Molecules. | 1.12e-06 | 13 | 56 | 3 | 28475893 | |
| Pubmed | 1.12e-06 | 13 | 56 | 3 | 18448090 | ||
| Pubmed | 1.54e-06 | 52 | 56 | 4 | 26633812 | ||
| Pubmed | 2.18e-06 | 16 | 56 | 3 | 21350012 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 32334335 | ||
| Pubmed | Starvation after AgRP neuron ablation is independent of melanocortin signaling. | 2.55e-06 | 2 | 56 | 2 | 18272480 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 17259277 | ||
| Pubmed | Defining the relative and combined contribution of CTCF and CTCFL to genomic regulation. | 2.55e-06 | 2 | 56 | 2 | 32393311 | |
| Pubmed | Ryanodine receptor oligomeric interaction: identification of a putative binding region. | 2.55e-06 | 2 | 56 | 2 | 14722100 | |
| Pubmed | Structural and functional interactions within ryanodine receptor. | 2.55e-06 | 2 | 56 | 2 | 26009179 | |
| Pubmed | Dissecting Integrin Expression and Function on Memory B Cells in Mice and Humans in Autoimmunity. | 2.55e-06 | 2 | 56 | 2 | 30949178 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 32899693 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 17960115 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 11488419 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 10702221 | ||
| Pubmed | Correlations of EZH2 and SMYD3 gene polymorphisms with breast cancer susceptibility and prognosis. | 2.55e-06 | 2 | 56 | 2 | 29089464 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 16415171 | ||
| Pubmed | Discovering a binary CTCF code with a little help from BORIS. | 2.55e-06 | 2 | 56 | 2 | 29077515 | |
| Pubmed | beta1 and beta2 integrins activate different signalling pathways in monocytes. | 2.55e-06 | 2 | 56 | 2 | 11931654 | |
| Pubmed | BORIS and CTCF are overexpressed in squamous intraepithelial lesions and cervical cancer. | 2.55e-06 | 2 | 56 | 2 | 26125810 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 24805197 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 1375903 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 23553099 | ||
| Pubmed | Ryanodine receptors in human pancreatic beta cells: localization and effects on insulin secretion. | 2.55e-06 | 2 | 56 | 2 | 15033925 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 28145452 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 11914080 | ||
| Pubmed | Disease-related quantitation of TGF-beta3 in human aqueous humor. | 2.55e-06 | 2 | 56 | 2 | 18049952 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 12191639 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 24501407 | ||
| Pubmed | SMYD3 regulates gastric cancer progression and macrophage polarization through EZH2 methylation. | 2.55e-06 | 2 | 56 | 2 | 36127410 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 22709888 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 18784302 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 30542613 | ||
| Pubmed | The combined action of CTCF and its testis-specific paralog BORIS is essential for spermatogenesis. | 2.55e-06 | 2 | 56 | 2 | 34158481 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 12183834 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 15280431 | ||
| Pubmed | Expression of the ryanodine receptor isoforms in immune cells. | 2.55e-06 | 2 | 56 | 2 | 11673493 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 24813658 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 11673462 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 12011441 | ||
| Pubmed | Crystal structures of wild type and disease mutant forms of the ryanodine receptor SPRY2 domain. | 2.55e-06 | 2 | 56 | 2 | 25370123 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 11984523 | ||
| Pubmed | Thermodynamics of calmodulin binding to cardiac and skeletal muscle ryanodine receptor ion channels. | 2.55e-06 | 2 | 56 | 2 | 18618700 | |
| Pubmed | TGF-beta-1 up-regulates extra-cellular matrix production in mouse hepatoblasts. | 3.17e-06 | 18 | 56 | 3 | 23041440 | |
| Pubmed | 5.15e-06 | 21 | 56 | 3 | 1970330 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 19062040 | ||
| Pubmed | Activity-dependent release of transforming growth factor-beta in a neuronal network in vitro. | 7.63e-06 | 3 | 56 | 2 | 17997227 | |
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 18403125 | ||
| Pubmed | A biochemical function for attractin in agouti-induced pigmentation and obesity. | 7.63e-06 | 3 | 56 | 2 | 11137996 | |
| Pubmed | TGF-beta knockout and dominant-negative receptor transgenic mice. | 7.63e-06 | 3 | 56 | 2 | 9525700 | |
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 22544282 | ||
| Pubmed | Differential expression of transforming growth factor-beta isoforms in bullous keratopathy corneas. | 7.63e-06 | 3 | 56 | 2 | 20142847 | |
| Pubmed | TGF-beta is required for programmed cell death in interdigital webs of the developing mouse limb. | 7.63e-06 | 3 | 56 | 2 | 11960699 | |
| Pubmed | Effects of AgRP inhibition on energy balance and metabolism in rodent models. | 7.63e-06 | 3 | 56 | 2 | 23762342 | |
| Pubmed | Activation of Epac stimulates integrin-dependent homing of progenitor cells. | 7.63e-06 | 3 | 56 | 2 | 18032709 | |
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 7876312 | ||
| Pubmed | Posttraumatic temporal TGF-β mRNA expression in lens epithelial cells of paediatric patients. | 7.63e-06 | 3 | 56 | 2 | 22464821 | |
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 24123915 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 18078367 | ||
| Pubmed | Excess TGF-β mediates muscle weakness associated with bone metastases in mice. | 7.63e-06 | 3 | 56 | 2 | 26457758 | |
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 8125201 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 16192636 | ||
| Pubmed | Differential expression of TGF beta isoforms in murine palatogenesis. | 7.63e-06 | 3 | 56 | 2 | 2401212 | |
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 20565961 | ||
| Pubmed | Isoform-specific effects of transforming growth factor β on endothelial-to-mesenchymal transition. | 7.63e-06 | 3 | 56 | 2 | 29856065 | |
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 16778279 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 23278119 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 29869452 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 18790002 | ||
| Pubmed | Transforming growth factor-beta isoform and receptor expression in chondrosarcoma of bone. | 7.63e-06 | 3 | 56 | 2 | 12021923 | |
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 22948152 | ||
| Pubmed | Characterization of L-plastin interaction with beta integrin and its regulation by micro-calpain. | 7.63e-06 | 3 | 56 | 2 | 20183869 | |
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 29320969 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 33728344 | ||
| Pubmed | Aberrant TGFβ Signaling Contributes to Altered Trophoblast Differentiation in Preeclampsia. | 7.63e-06 | 3 | 56 | 2 | 26653761 | |
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 1723948 | ||
| Pubmed | Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain. | 7.63e-06 | 3 | 56 | 2 | 10788707 | |
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 1577201 | ||
| Pubmed | Transforming growth factor-beta. A family of growth regulatory peptides. | 7.63e-06 | 3 | 56 | 2 | 2375595 | |
| Pubmed | Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor. | 7.63e-06 | 3 | 56 | 2 | 7621815 | |
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 1707784 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 17311314 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 14966285 | ||
| Pubmed | Wiz binds active promoters and CTCF-binding sites and is required for normal behaviour in the mouse. | 7.63e-06 | 3 | 56 | 2 | 27410475 | |
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 18080134 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 29174711 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 35705732 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 26410369 | ||
| Pubmed | Molecular identification of the ryanodine receptor pore-forming segment. | 7.63e-06 | 3 | 56 | 2 | 10473538 | |
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 36006052 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 16210002 | ||
| Interaction | UNC5D interactions | 1.01e-06 | 8 | 54 | 3 | int:UNC5D | |
| Interaction | UNC5A interactions | 1.51e-06 | 9 | 54 | 3 | int:UNC5A | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 1.11e-06 | 34 | 42 | 4 | 487 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 1.58e-05 | 3 | 42 | 2 | 287 | |
| GeneFamily | Zinc fingers HIT-type | 7.86e-05 | 6 | 42 | 2 | 83 | |
| GeneFamily | CD molecules|Integrin beta subunits | 1.88e-04 | 9 | 42 | 2 | 1159 | |
| GeneFamily | LIM domain containing | 3.46e-04 | 59 | 42 | 3 | 1218 | |
| GeneFamily | Fibronectin type III domain containing | 5.09e-04 | 160 | 42 | 4 | 555 | |
| GeneFamily | Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors | 2.35e-03 | 31 | 42 | 2 | 81 | |
| GeneFamily | Ring finger proteins | 3.72e-03 | 275 | 42 | 4 | 58 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 8.51e-03 | 181 | 42 | 3 | 694 | |
| GeneFamily | Endogenous ligands | 1.75e-02 | 237 | 42 | 3 | 542 | |
| Coexpression | NABA_MATRISOME | VEGFC TGFB2 TGFB3 SBSPON WNT9A OGFOD2 ADAMTS20 COL6A5 MUC5B PLXNB2 OTOG | 7.84e-06 | 1008 | 56 | 11 | MM17056 |
| Coexpression | NABA_MATRISOME | VEGFC TGFB2 TGFB3 SBSPON WNT9A OGFOD2 ADAMTS20 COL6A5 MUC5B PLXNB2 OTOG | 9.27e-06 | 1026 | 56 | 11 | M5889 |
| ToppCell | P15-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.81e-06 | 176 | 56 | 5 | 792f414f5092aba14260b8e16378e793a822498e | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.68e-06 | 186 | 56 | 5 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.88e-06 | 188 | 56 | 5 | e9cef856a96a97afac5ecafe2ee91eff0d731e01 | |
| ToppCell | facs-Trachea-3m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_tracheal_l15|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.39e-05 | 164 | 56 | 4 | 5ca7b69684a8bb12dd0b45e7ad94e30d16ed01ce | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.20e-05 | 170 | 56 | 4 | 6686d1797988216c0d9417f21a2537369abce410 | |
| ToppCell | droplet-Trachea-3m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_tracheal_l15|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.34e-05 | 171 | 56 | 4 | 87cb65648c663e246f94cea1a5ed12e8e29ec629 | |
| ToppCell | droplet-Kidney-nan-21m-Lymphocytic-lymphocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.34e-05 | 171 | 56 | 4 | 0385d5834ae16bbb0c6a68893fec60e4dd1e478d | |
| ToppCell | droplet-Thymus-nan-3m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.34e-05 | 171 | 56 | 4 | 25493a4a7b636920e2cfd984542cc500709c9dcf | |
| ToppCell | droplet-Kidney-nan-21m-Lymphocytic-CD45|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.34e-05 | 171 | 56 | 4 | a3e3fe0cbab21abb178c482f5951e576529f7e30 | |
| ToppCell | droplet-Thymus-nan-3m-Myeloid-professional_antigen_presenting_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.34e-05 | 171 | 56 | 4 | 508b41e3ad2638f9dd546d251b13ff60fc8c3207 | |
| ToppCell | Lymphoid-Lymphoid-B_cells_(cycle)|Lymphoid / shred on cell class and cell subclass (v4) | 6.49e-05 | 172 | 56 | 4 | f39822afcc35f0fbf68b8ffd1894e4b6c8d7a80c | |
| ToppCell | facs-Trachea-18m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_tracheal_l15|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.49e-05 | 172 | 56 | 4 | eaba10a4d4eaab42ad2e2da65ebb20b50edaf815 | |
| ToppCell | 11.5-Distal-Mesenchymal-Mesenchyme_SERPINF1-high|Distal / Age, Tissue, Lineage and Cell class | 6.63e-05 | 173 | 56 | 4 | 6989c9cebcd81eccceac7e5a86152676ee959386 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.78e-05 | 174 | 56 | 4 | d5c22b43531414951666ee7542a66ed9380e2d14 | |
| ToppCell | facs-Trachea-24m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_tracheal_l15|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.78e-05 | 174 | 56 | 4 | c52aed2ffe9c648e5f23e3459e2d331d6ca214e3 | |
| ToppCell | AT1_cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 7.09e-05 | 176 | 56 | 4 | 4a30bb771297b30926fb98e2b5ec0dbdc46feac7 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.25e-05 | 177 | 56 | 4 | 382f0d6bbff01e84b0c7840e74ac865864e6da89 | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.25e-05 | 177 | 56 | 4 | e73e2b6a72630bb56ac2af1cdeedc8f0f828f390 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.25e-05 | 177 | 56 | 4 | 6b4fe717928814dafcd13090b1c90ea973938c6d | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.6.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.25e-05 | 177 | 56 | 4 | 929cd8f530ce001623735da53b7278d02522e2b5 | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.57e-05 | 179 | 56 | 4 | 33ed9270d257895ff3b40df2c1af878119c9f492 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.74e-05 | 180 | 56 | 4 | 2bc3fd2e4c249bf236340c5f0483747faa5c04ec | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.90e-05 | 181 | 56 | 4 | 1b4eb044825ede6361928442524b1988c8ef58b3 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.90e-05 | 181 | 56 | 4 | 7af469f5bcb9b1ab3f35b2758bf2afb87e8eba57 | |
| ToppCell | cellseq2-Immune-Immune_Myeloid-AM|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.90e-05 | 181 | 56 | 4 | d4ab8ab41bf3e6f1937e919662456d7c9551eeab | |
| ToppCell | cellseq2-Immune-Immune_Myeloid-AM-AM|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.90e-05 | 181 | 56 | 4 | 45fc9c27ea60312a118a2a6c1eb635d776fde295 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Dendritic|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.90e-05 | 181 | 56 | 4 | 8d7ebbedc373d55e29da02ac2728b4f4118038f2 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.90e-05 | 181 | 56 | 4 | c8286a7ac8e3cc5aa7e92b043a08435294ea686f | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.07e-05 | 182 | 56 | 4 | 9465238ac806fce46dfe1a141e83893f23eb4afb | |
| ToppCell | COVID-19-lung-AT1|lung / Disease (COVID-19 only), tissue and cell type | 8.25e-05 | 183 | 56 | 4 | 942530449e9c6583705eeb8f6f12621daea57252 | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.25e-05 | 183 | 56 | 4 | 107cc756c45d6e92181659868d91188814dae66d | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.42e-05 | 184 | 56 | 4 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.42e-05 | 184 | 56 | 4 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.42e-05 | 184 | 56 | 4 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.42e-05 | 184 | 56 | 4 | bc0dfe29337f02594e7e0092c9e47dda94b45ad5 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.15e-05 | 188 | 56 | 4 | 4d1e5f85342ae550086609d7680e32730b78b5d2 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.15e-05 | 188 | 56 | 4 | cb091912f9b627a78a8793a37df7f1de839f887f | |
| ToppCell | droplet-Heart-HEART-1m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.34e-05 | 189 | 56 | 4 | a618a1ddf5097a010c6c2c7341f3a0bd46a29c02 | |
| ToppCell | droplet-Heart-HEART-1m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.34e-05 | 189 | 56 | 4 | 4e61f9cd1c06bddb47ebf98affc0f97770e26e8c | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial-filiform|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.53e-05 | 190 | 56 | 4 | 251e3a33041023bfc4b547c7eb68cfb8f421636f | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-filiform|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.53e-05 | 190 | 56 | 4 | 8a53f4d3c9aca45b5826f53f7dcdfb8bc8280acb | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-Macrophages|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.73e-05 | 191 | 56 | 4 | 94c7da03e5264f4d73bb507ce339a935d90279a0 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.73e-05 | 191 | 56 | 4 | b5715eeb72a97b7bc87b83f6c289e225f58da842 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.92e-05 | 192 | 56 | 4 | 0dc1f46e40346ed0b286e53b106a812441575100 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.01e-04 | 193 | 56 | 4 | 50c2832de75b6469f649355c6b9a75e910d32db3 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.01e-04 | 193 | 56 | 4 | 222829c30ebe47f0ed1e035897e3cd4be10b2a11 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-Myeloid-Macrophages|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.03e-04 | 194 | 56 | 4 | 7c7091de47359760003e910cfbe63db5c99410d6 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.05e-04 | 195 | 56 | 4 | a71ba5e4043e2d35a45a2c60a96b087e31832345 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.05e-04 | 195 | 56 | 4 | 4cbc36fb3ef9aef61367d3b37070a9a85fae1418 | |
| ToppCell | (1)_Osterolineage_cells-(11)_OLC-2|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.05e-04 | 195 | 56 | 4 | 78978d85273e5463a7f43e4c121e647fa6aba42b | |
| ToppCell | 10x5'-blood-Myeloid_Monocytic-Nonclassical_monocytes|blood / Manually curated celltypes from each tissue | 1.05e-04 | 195 | 56 | 4 | 88d65c7c3a28922c125bd9f7c403a55d7d4d83a9 | |
| ToppCell | ILEUM-non-inflamed-(9)_Enteric_neurons|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.07e-04 | 196 | 56 | 4 | 998aa523555ed6bc9c1b5cacbf7ba77c7b218e6b | |
| ToppCell | ILEUM-non-inflamed-(9)_Neuro_cell|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.07e-04 | 196 | 56 | 4 | 2b08cd6730119d5dea0152709ab8de580b66cd3c | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 196 | 56 | 4 | 2029f58ce6a7b8c35d3a7496c3341391990909ce | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.10e-04 | 197 | 56 | 4 | 9d7a1c7dc70ba5e35645f19f9e056e4fa2494aa0 | |
| ToppCell | Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.12e-04 | 198 | 56 | 4 | ab70bf89690410221ec7aa3149bb50ac34433f99 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-non-classical_monocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.12e-04 | 198 | 56 | 4 | ecf1cb56bdd43b9c62cec3fcf914ede608a7c8a0 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.12e-04 | 198 | 56 | 4 | b258f672529fb2c03e62e2696d335043c4963280 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-Glial_immature|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.12e-04 | 198 | 56 | 4 | c8272ac4d90f2367f538f66db40de911ad73ea7f | |
| ToppCell | Monocytes|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.12e-04 | 198 | 56 | 4 | 8beccf03c9ec9cd02a96107a9d7ca9a6764c6a61 | |
| ToppCell | Severe_COVID-19-Myeloid-MoAM3|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.14e-04 | 199 | 56 | 4 | 30523cf08815ca214877e33a2c52197ff8318557 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_monocytic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.14e-04 | 199 | 56 | 4 | 7dde5c02fcae64cd2d68f607500f2a46b97851fd | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM3|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.14e-04 | 199 | 56 | 4 | 105709b97c55826a852aed27658e3b4af1738c8a | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.14e-04 | 199 | 56 | 4 | 0a145172787f40d0fdaf21188d539ffaf7ece3e4 | |
| ToppCell | COVID-19-Myeloid-MoAM3,_VCAN|COVID-19 / Condition, Lineage and Cell class | 1.14e-04 | 199 | 56 | 4 | aba0b833e44fe42625fac91466f6ebaa8e786d3b | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.14e-04 | 199 | 56 | 4 | 0892957a49304ce4b6daa3657d76d8365ce0dd19 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM3-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.14e-04 | 199 | 56 | 4 | b2dc3d0af6ecd3ab01779aaa1f061cb0f941cae8 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_monocytic-monocyte|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.14e-04 | 199 | 56 | 4 | 84879280851380e5bfe6bd48b6bbf57aedf6e003 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Myeloid-Microglia|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.14e-04 | 199 | 56 | 4 | 4ddfbcaa8054b69b3398d8c0d5fab8ae94805cb9 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM3-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.14e-04 | 199 | 56 | 4 | 961ad44199871be8e09d31904d383edc865ba262 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.14e-04 | 199 | 56 | 4 | 81b3cb41abbee9785041170d0469edc50b622d7e | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.14e-04 | 199 | 56 | 4 | 8d13a9ea87f685b5a34b84c4571db6be753cf2d9 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.14e-04 | 199 | 56 | 4 | df946601b295be5419c09befbfa73f4314eef116 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.0.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.14e-04 | 199 | 56 | 4 | 53dac0455b84597460457ed429969a42ed0fe932 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.14e-04 | 199 | 56 | 4 | 3216fdaba8be8e8e715aceb2c29f1ad5cc02f8ae | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Myeloid|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.14e-04 | 199 | 56 | 4 | 3ba48a4715d5e9387650aa97e0c5d7f7897bf380 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-04 | 200 | 56 | 4 | 4657d18e92abde7f0b8b7e4fc9fa0081efe20a55 | |
| ToppCell | COVID_vent-Myeloid|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.16e-04 | 200 | 56 | 4 | 621af09aae34226902c03edf556562f3ab35a7d8 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.16e-04 | 200 | 56 | 4 | 94679f6914dab1551ce1c58542a65c339254451d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.16e-04 | 200 | 56 | 4 | b719af4e821f371459344693458bfd316cc2b37c | |
| ToppCell | COVID_vent-Myeloid-Monocytic-CD14+_Monocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.16e-04 | 200 | 56 | 4 | e57452b73abb21cb3f645d45523ab93f6bef0243 | |
| ToppCell | COVID_vent-Myeloid-Monocytic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.16e-04 | 200 | 56 | 4 | b0a5bee87700ce38f26f95a6f491da7e27cade51 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-04 | 200 | 56 | 4 | f1255d4de08134bd0a95296c8cc743e90044d2ff | |
| ToppCell | COVID_non-vent-Myeloid|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.16e-04 | 200 | 56 | 4 | a40768e8e58c86b8e20bc188b9274ebe412fc765 | |
| ToppCell | mild-Myeloid-CD14_Monocytes_1|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.16e-04 | 200 | 56 | 4 | 3874c1f078cb8789be2e2275a202357c711b1be3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Classical_Monocyte|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.16e-04 | 200 | 56 | 4 | 3408641b60c4cbc99da3f0cce7bf3d5247370f5f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.16e-04 | 200 | 56 | 4 | 11f6c597eca9c770d61a8cba83b26cde5fc7222d | |
| ToppCell | COVID_non-vent-Myeloid-Monocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.16e-04 | 200 | 56 | 4 | 4243a9d32f3a11141284d0d944cb81194b532876 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.16e-04 | 200 | 56 | 4 | 1bf1be3461d8498454f1a064437bfbe2c0baa3ac | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Monocytic-Nonclassical_Monocyte|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.16e-04 | 200 | 56 | 4 | 97f261d56bc6c55683eb4c42670d00b9a6992a26 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Rxfp1_Eya1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.51e-04 | 82 | 56 | 3 | 42017b8ace6f142a8358213c95a2632226c3a867 | |
| ToppCell | COVID-19-Heart-Fib_+_CM|Heart / Disease (COVID-19 only), tissue and cell type | 3.04e-04 | 104 | 56 | 3 | 0b60a56a46f1fe3f8224ec6399d009a34a117a21 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Interneuron|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 4.74e-04 | 121 | 56 | 3 | b2d571f571133c281d72584fe925cebbd2317829 | |
| ToppCell | COVID-19_Severe-Neu_3|World / 5 Neutrophil clusters in COVID-19 patients | 5.09e-04 | 124 | 56 | 3 | 54b42ffb161eece4ae308782e43a0e0dc360281e | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Nxph3|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.95e-04 | 138 | 56 | 3 | b63e26afafbd2cdeed9c9451e6f530ab6295504c | |
| ToppCell | Lymphoid-Lymphoid-NK_cells|Lymphoid / shred on cell class and cell subclass (v4) | 8.51e-04 | 148 | 56 | 3 | d51a4b654a88d58dcdf29c2bc362c0cc1c40723a | |
| ToppCell | droplet-Fat-Scat-21m-Myeloid-monocyte|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.85e-04 | 150 | 56 | 3 | b6e5e04aaf1c5265ac07581868d3159f9292a84c | |
| ToppCell | LPS-antiTNF-Endothelial-Epi-like-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.85e-04 | 150 | 56 | 3 | 9cb3332924bd67c966873343c14445e30d3f384f | |
| ToppCell | P15-Epithelial-epithelial_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.19e-04 | 152 | 56 | 3 | 00d5503d462cfa009fb4cac79ecee11725a18b9a | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Conventional_Leiomyosarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 9.37e-04 | 153 | 56 | 3 | ec6fe6b8c884fa76adc7a0f9db041f7b1567a2ee | |
| Computational | T-cell proliferation genes. | 1.45e-04 | 36 | 31 | 3 | MODULE_521 | |
| Drug | 2-nitrotoluene | 1.54e-05 | 61 | 56 | 4 | ctd:C029955 | |
| Drug | 2-hydroxycarbazole | 1.78e-05 | 3 | 56 | 2 | CID000093551 | |
| Drug | cis-diammineplatinum(II | 1.78e-05 | 3 | 56 | 2 | CID000159790 | |
| Drug | 2-hydroxyheptanoic acid | 1.78e-05 | 3 | 56 | 2 | CID002750949 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 1.78e-05 | 3 | 56 | 2 | CID005748312 | |
| Drug | 8N3-cADPR | 1.78e-05 | 3 | 56 | 2 | CID000127713 | |
| Drug | aminodantrolene | 1.78e-05 | 3 | 56 | 2 | CID009570289 | |
| Drug | MW 1 | 3.49e-05 | 151 | 56 | 5 | CID000073965 | |
| Drug | PCB74 | 3.55e-05 | 4 | 56 | 2 | CID000036218 | |
| Drug | 148504-47-6 | 3.55e-05 | 4 | 56 | 2 | CID006444275 | |
| Drug | SC 38249 | 3.55e-05 | 4 | 56 | 2 | CID000134834 | |
| Drug | AC1L1U7A | 3.55e-05 | 4 | 56 | 2 | CID000035682 | |
| Drug | AC1O3MMZ | 3.55e-05 | 4 | 56 | 2 | CID006332294 | |
| Drug | 2-(2,6-dioxopiperidin-3-yl)phthalimidine | 5.91e-05 | 5 | 56 | 2 | ctd:C001079 | |
| Drug | Chlorthalidone | 5.91e-05 | 5 | 56 | 2 | ctd:D002752 | |
| Drug | A 68930 | 5.91e-05 | 5 | 56 | 2 | ctd:C065380 | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 8.05e-05 | 180 | 56 | 5 | 6886_DN | |
| Drug | MBED | 8.86e-05 | 6 | 56 | 2 | CID000129958 | |
| Drug | chloro-m-cresol | 8.86e-05 | 6 | 56 | 2 | CID000012008 | |
| Drug | AC1O528X | 8.86e-05 | 6 | 56 | 2 | CID006475857 | |
| Drug | NSC114784 | 8.86e-05 | 6 | 56 | 2 | CID000419425 | |
| Drug | Azacytidine-5 [320-67-2]; Up 200; 16.4uM; MCF7; HT_HG-U133A | 1.12e-04 | 193 | 56 | 5 | 3348_UP | |
| Drug | Azumoleno | 1.24e-04 | 7 | 56 | 2 | CID000056259 | |
| Drug | Br2BAPTA | 1.24e-04 | 7 | 56 | 2 | CID003081001 | |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 1.24e-04 | 7 | 56 | 2 | CID009547999 | |
| Drug | 1d3q | 1.31e-04 | 40 | 56 | 3 | CID000001635 | |
| Drug | bromochloroacetic acid | 1.51e-04 | 109 | 56 | 4 | ctd:C099813 | |
| Disease | osteochondrodysplasia (biomarker_via_orthology) | 3.41e-06 | 2 | 55 | 2 | DOID:2256 (biomarker_via_orthology) | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 1.02e-05 | 3 | 55 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | Congenital abnormality of respiratory system | 1.02e-05 | 3 | 55 | 2 | C0035238 | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 1.02e-05 | 3 | 55 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | Loeys-Dietz Aortic Aneurysm Syndrome | 3.40e-05 | 5 | 55 | 2 | C1836635 | |
| Disease | Loeys-Dietz Syndrome, Type 1a | 3.40e-05 | 5 | 55 | 2 | C4551955 | |
| Disease | Loeys-Dietz Syndrome | 7.12e-05 | 7 | 55 | 2 | C2697932 | |
| Disease | pancreatic cancer (biomarker_via_orthology) | 7.12e-05 | 7 | 55 | 2 | DOID:1793 (biomarker_via_orthology) | |
| Disease | Leukemia, Megakaryoblastic, of Down Syndrome | 9.48e-05 | 8 | 55 | 2 | C1860789 | |
| Disease | arrhythmogenic right ventricular cardiomyopathy (is_implicated_in) | 1.52e-04 | 10 | 55 | 2 | DOID:0050431 (is_implicated_in) | |
| Disease | Cognitive impairment | 1.86e-04 | 11 | 55 | 2 | HP_0100543 | |
| Disease | Chromosome Breaks | 3.06e-04 | 14 | 55 | 2 | C0333704 | |
| Disease | Chromosome Breakage | 3.06e-04 | 14 | 55 | 2 | C0376628 | |
| Disease | Pulmonary Emphysema | 4.56e-04 | 17 | 55 | 2 | C0034067 | |
| Disease | diabetic neuropathy (biomarker_via_orthology) | 4.56e-04 | 17 | 55 | 2 | DOID:9743 (biomarker_via_orthology) | |
| Disease | selenium measurement, response to dietary selenium supplementation | 6.34e-04 | 20 | 55 | 2 | EFO_0006331, EFO_0600021 | |
| Disease | pancreatic ductal adenocarcinoma (is_marker_for) | 1.16e-03 | 27 | 55 | 2 | DOID:3498 (is_marker_for) | |
| Disease | congestive heart failure (is_implicated_in) | 1.16e-03 | 27 | 55 | 2 | DOID:6000 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CCDPCATCYCRFFNA | 101 | O00253 | |
| GERPFQCCQCSYASR | 366 | Q8NI51 | |
| FQCELCSYTCPRRSN | 266 | P49711 | |
| LICGNPDCTRCYCFE | 106 | Q9UJW3 | |
| FICCFALRKRRCPNC | 106 | O95415 | |
| DCRLYCDPEACACSQ | 216 | Q9H175 | |
| WACCPYRQGVCCADR | 541 | P28799 | |
| CPSVCRCDAGFIYCN | 31 | Q9NZU0 | |
| RLRYSVCCKVCPNFC | 116 | Q96MU5 | |
| RVQCNRCNEVFCFKC | 246 | O95376 | |
| RFRQACLETCARCCP | 396 | P32239 | |
| DCPNCNYRRRCACDD | 201 | P78312 | |
| CPSVCRCDRNFVYCN | 36 | O43155 | |
| YQCPFNGSRREDCEC | 1776 | P59510 | |
| ACCDPCASCQCRFFR | 106 | P42127 | |
| DCCPTFRCRPQLCSY | 5511 | Q9HC84 | |
| CRVCECNPNYTGSAC | 576 | P05556 | |
| LDCFACQLCNQRFCV | 111 | P25800 | |
| CRCACFCTDNLYVAR | 11 | Q6N063 | |
| CDNCYQQQDNLCPFC | 456 | Q8NEZ4 | |
| YHPGCFRCVICNECL | 556 | Q9UGP4 | |
| FCQCSSECQNRFPGC | 546 | Q15910 | |
| DCSLCRAANPDYRCA | 766 | O15031 | |
| DCFACQLCNQRFCVG | 101 | Q8TAP4 | |
| CRGQRCPCYSNRKAC | 476 | Q9HCI7 | |
| RSQHICCYECQNCPE | 536 | Q5T6X5 | |
| CRCNVCECHSGYQLP | 596 | P05107 | |
| CYRVYCCCCLANVSL | 271 | A4D1U4 | |
| RRCALCYDKCFPNAC | 1936 | A8TX70 | |
| CRACGYVVCARCSDY | 481 | Q7Z6J4 | |
| CRCHRPYCEICFQSS | 756 | Q8NFN8 | |
| CPSVCRCDNGFIYCN | 26 | Q9NZU1 | |
| QCCFCSCINDVPPQY | 446 | P53992 | |
| SCCRFLCYFCRISRQ | 2231 | P21817 | |
| CCRFLCYFCRISRQN | 2196 | Q92736 | |
| TELCCPLYQCVCENF | 2601 | Q6ZRI0 | |
| NCTCFPCPYKDERNC | 36 | Q8IWZ5 | |
| PCPYKDERNCQFCHC | 41 | Q8IWZ5 | |
| VAYCCRFDVQVCSRQ | 456 | Q8IUH8 | |
| CSQCNTNFCYRCGER | 441 | Q8TC41 | |
| LCGYCSFCNRCTECE | 626 | P23327 | |
| QYCFECDCFRCQTQD | 256 | Q9H7B4 | |
| ECNSRCRCGYDCPNR | 221 | O43463 | |
| AAYCFRNVQDNCCLR | 306 | P61812 | |
| PLTRKCCYRACFRQC | 56 | Q8TCV5 | |
| CCYRACFRQCVPRVS | 61 | Q8TCV5 | |
| CSCYRRPCTNRQKAC | 381 | P49767 | |
| AARCVCPFCQRELYE | 136 | Q96EQ8 | |
| CRFTGDCCFDYDRAC | 56 | Q8IVN8 | |
| DCCFDYDRACPARPC | 61 | Q8IVN8 | |
| CCFPTFLNARACACA | 1256 | Q8IWN7 | |
| EGQRCHRFACNTCPY | 16 | Q9Y2Y1 | |
| CQCCDCGRVFSRNSY | 466 | Q9NZV7 | |
| TCPRCNAPYCSLRCY | 21 | Q9UHR6 | |
| TRPCQCQVRWCCYVE | 336 | O14904 | |
| CRFNTQCTRPDCTFY | 701 | Q6PJT7 | |
| RCPACRVPYCSVVCF | 21 | Q15649 | |
| CRENPARVCDQCYSY | 1856 | Q68DK2 | |
| YCFRNLEENCCVRPL | 306 | P10600 |